In conclusion, we show that CD4+CD25+ Treg appear to have little effect on the number, phenotype and function of TIDC in B16 melanoma, suggesting that the delayed tumor growth observed in Treg-depleted mice is unlikely to be due to improved DC function. Here, CD4 is linked to neoplasm.